C4 Consortium

 
You are here: Home Technologies C4 Technologies on Flintbox
Document Actions

C4 Technologies on Flintbox

by C4 Web Admin last modified 2007-05-14 11:22

C4 markets many of its technologies through Flintbox.

2007-04-27 Complete Self-Assembled Monolayers Of Octadecylphosphonic Acid (OPA) on Silicon and Metal Surfaces
University of Western Ontario researchers have developed a reproducible process for fabricating a complete and apparently defect-free OPA monolayer, which will find uses in nanometer scale surface engineering and other applications where an organic monolayer is required.
2007-04-19 TCM Employee Commitment Survey - Academic Package
Based on the Three-Component Model (TCM) of commitment (Meyer & Allen, 1991; 1997), the TCM Employee Commitment Survey measures three forms of employee commitment to an organization: desire-based, obligation- based and cost-based to create employee " commitment profiles. " < br > < br > The Academic Package has been designed specifically for use by students and academic researchers. The package co
2007-04-09 Veterinary Ultrasound Video
Training video describing the use of ultrasound on dogs, complete with precise labelling of organs and structures and expert narration.
2007-02-27 PYROX Model software for Sulfide Oxidation
PYROX is a numerical model that simulates one-dimensional, kinetically controlled diffusion of oxygen into the vadose zone of mine tailings and the subsequent oxidation of sulfide minerals, such as pyrite.
2006-12-18 Regenerative Snubber Circuit for High-Power DC\DC Boost Converters
The University of Waterloo has developed a novel regenerative snubber circuit to be used in high-power DC\DC boost converters. The snubber circuit can operate at a switching frequency of 70kHz and it significantly reduces turn-off losses of the main switch.
2006-04-24 RECAP-FS Cancer Formulary Software
RECAP-FS is a user-friendly tool that automates the process of creating, updating, archiving and printing regimen and clinical trial information.
2006-04-17 Elite Medicinal Plants
Guelph researchers have developed a method to produced standardized, elite medicinal plants with high yields of active ingredients. < br > < br > Major problems with existing methods to produce medicinal plants are variability between seasons and plants, contamination with other species or disease, and lack of understanding of plant physiology. The current method solves those problems by producing
2005-05-25 Screening Compounds for Interaction with the MDR1 Multidrug Transporter
Guelph researchers have developed a novel screening method to determine the strength of a compound s interaction with the MDR1 P glycoprotein (Pgp), an ABC transporter which is involved in multiple drug resistance. Strong interaction with Pgp suggests that a compound will have poor absorption in the gut, very limited entry to the brain, and will be unable to enter drug resistant tumors. < br > < b
2005-05-02 Method to Differentiate Skin Stem Cells into Oocytes
A goal of stem cell research is to discover methods to show increased potency for cells other than embryonic stem cells. Researchers at Guelph have discovered a method of isolating porcine skin stem cells and differentiating them into germ cells (oocytes, theca cells, granulosa cells).
2005-04-07 Maple Nut (TM) Popcorn
Maple Nut (TM) is a hybrid, two-eared popcorn variety. It has a red pericarp and cob, and has a unique nutty flavour.
2005-01-21 Diagnostic Test For Epitheliogenesis Imperfecta (EI) In Horses
This invention consists of a genetic mutation in the laminin-5 2 gene responsible for Herlitz-Junctional Epidermolysis Bullosa (H-JEB) in draft horses, as well as a diagnostic method to identify carriers of the mutation in the breeding population. H-JEB is more commonly known as epitheliogenesis imperfecta or EI .
2005-01-20 Potential Treatment for Polycystic Kidney Disease
This invention relates to method to treat polycystic kidney disease (PKD) using a saponin-enriched alcohol extract from soy protein isolate. Kidney morphometric analysis shows that mean cyst volume, and hence cyst size, is significantly reduced in rodent models of PKD.